|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | 4-Arylazo-3,5-diamino-1H-pyrazole CDK inhibitors:SAR study,crystal structure in complex with CDK2,selectivity,and cellular effects显示文摘 | KRYSTOF V CANKAR P FRYSOV I | 2006 | J Med Chem2006，49，22： | 1 |
| 2 | The selective P-TEFb inhibitor CAN508 targets angiogenesis显示文摘 | KRYSTOF V RROVL LIEBL J | 2011 | Eur J Med Chem2011，46，9： | 1 |
| 3 | 4-Ary-lazo-3,5-diamino-1H-pyrazole CDK inhibitors显示文摘 | KRYSTOF V CANKAR P FRYSOVA I | | 0，，22： | 1 |
| 4 | Cyclin-dependent kinase inhibitors inspired by roscovitine:purinebioisosteres显示文摘 | Jorda R Paruch K Krystof V | | 0，，20： | 1 |
| 5 | Cyclin-dependent kinase inhibitors as anti- cancer drugs显示文摘 | Krystof V Uldrijan S | 2010 | Curr Drug Targets2010，11，3： | 1 |
| 6 | Cyclin dependent kinase inhibitors as anticancer drugs显示文摘 | Krystof V Uldrijan S | 2010 | Curr Drug Targets2010，11，3： | 1 |
| 7 | Docking-based development of purine-like inhibitors of cyclin-dependent kinase-2显示文摘 | Otyepka M Krystof V Havlicek L | 2000 | J Med Chem2000，43，： | 1 |
| 8 | Cyclin-dependent kinase inhibitors as anticancer drugs显示文摘 | KRYSTOF V ULDRIJAN S | 2010 | Curr Drug Targets2010，11，3： | 1 |
| 9 | Antiproliferactivity of Olomoucine II , a noval 2,6,9-trisubstituted purine cyclin-dependent kinase inhibitor显示文摘 | Krystof V McNae IW Walkinshaw MD | 2005 | Cell Mol Life Sci2005，62，15： | 1 |
| 10 | Cyclin-dependent kinase inhibitors as anticancer drugs 显示文摘 | Krystof V Uldrijan S | 2010 | Curr Drug Targets2010，11，3： | 1 |
| 11 | Synthesis and biological activity of 8-azapu- fine and pyrazolopyrimidine analogues of myoseverin 显示文摘 | KRYSTOF V | 2006 | European Journal of Medicinal Chemistry2006，41，12： | 1 |
| 12 | Antiproliferative activity of olomoucine Ⅱ,a noval 2,6,9-trisubstituted purine cyclin-dependent kinase inhibitor显示文摘 | Krystof V McNae IW Walkinshaw MD | 2005 | Cell Mol Life Sc2005，62，15： | 1 |
| 13 | 8-Azapurines as new inhibitors of cyclin dependent kinases显示文摘 | HAVLICEK L FUKSOVA K KRYSTOF V | 2005 | Bioorg Med Chem2005，13，18： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员